REPLIGEN CORP
Develops bioprocessing technologies and systems for biologic drug manufacturing.
RGEN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7599161095
- LEI:
- Country:
- United States of America
- Address:
- 41 SEYON STREET, 2453 WALTHAM
- Website:
- https://www.repligen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of special-purpose machinery
Description
Repligen Corporation is a global life sciences company, founded in 1981, that develops and commercializes innovative bioprocessing technologies and systems. The company is focused on providing critical solutions for the manufacturing of biological drugs, serving biopharmaceutical manufacturers from process development through to cGMP manufacturing. Its comprehensive portfolio is organized into key franchises including Filtration (e.g., Tangential Flow Filtration), Fluid Management (e.g., single-use mixing and storage solutions), Chromatography, and Process Analytics. Repligen expands its offerings through both internal innovation and strategic acquisitions to enhance its leadership in the bioprocessing industry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all REPLIGEN CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for REPLIGEN CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for REPLIGEN CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
